FSD Pharma Inc. (HUGE) Stock Overview
Explore FSD Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.
FSD Pharma Inc. (HUGE)
Key Financials
Key Financials
Market Cap
66.7K
P/E Ratio
-0.19
EPS (TTM)
$-16.25
ROE
-0.85%
HUGE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of FSD Pharma Inc. (HUGE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.19 and a market capitalization of 66.7K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.